Marija Butkovic

Karen Silverman

Karen is a leading global expert in practical governance strategies for AI and other frontier technologies. As the CEO and Founder of The Cantellus Group, she advises Fortune 50 companies, startups, consortia, and the public sector on how to manage cutting-edge technologies in a rapidly changing policy environment. Her expertise is informed by more than 20 years of practice and management leadership at Latham & Watkins, LLP where she advised global businesses in complex antitrust matters, M&A, governance, ESG, and crisis management. Karen chairs the board of a public benefit corporation developing complex content moderation tools. She is an SME for the Business Roundtable's Responsible AI Initiative, and a World Economic Forum Global Innovator and Karen sits on its Global AI Council. She serves on the boards of Krunam, AI.EDU, Legal Momentum and Not For Sale.

Farah Anwar

Farah Anwar is the Head of Clinical Development Operations at Sana and serves as the Leader of Inclusion, Diversity and Equity.

Farah has been chairing Sana’s diversity committee, Voices at Sana since it’s inception in 2018.  She was most recently Vice President, Clinical Operations at Juno Therapeutics.  Previously she was Executive Director, Global Commercial Planning at Ultragenyx Pharmaceuticals where she helped build out the Global Commercial organization and served as Chief of Staff to the Chief Commercial Officer.

Farah served in various roles in strategic operations and study management at Genentech including Head of Study Management for Immunology, Infectious Disease, Ophthalmology and Neuroscience overseeing 15 products in various phases of development and 100+ clinical trials. Earlier in her career, Farah was at MedImmune where she started in Medical Affairs then worked as a Clinical Program Lead in Development working on infectious disease programs.

Farah holds a BS in Physical Therapy from the University of Maryland, a MS in Clinical Research Administration from the George Washington University and a certificate in Inclusion, Diversity and Equity from Cornell University.

Ben Hansen

Ben Hansen is the Product Engineering Lead- AI & Sports Technology for Intel’s Olympic Technology Group. Hansen leads product development for 3D Athlete Tracking (3DAT), a cloud- and edge-based markerless motion capture SDK for sports, health, and fitness industries. The 3DAT SDK can be integrated with single or multiple video cameras to provide lab-grade 3D skeletal tracking and biomechanics data, enabling developers to create real-time and engaging experiences to improve human performance and mitigate risk. 

Prior to joining Intel, Hansen spent 2 years as a Senior Biomechanical Engineer with the Chicago White Sox, overseeing the acquisition of Motus Global’s biomechanics lab, databases, and wearable IMU IP and source code. Hansen spent 8 years serving as CTO and VP of Biomechanics at Motus Global, pioneering wearable technology for sports and MSK applications alongside contracting biomechanics lab services to sports teams. 

Hansen has a B.S. in biomedical engineering and mathematics from the Milwaukee School of Engineering. During his Ph.D. studies at Marquette University (biomedical engineering), Hansen was a motion capture technician for the Milwaukee Brewers and was a summer intern at the American Sports Medicine Institute. Hansen departed his studies to join Motus Global as their first employee.

Shawn Rizvi

Shawn (CIPP, CDPSE) has over 10 years of experience in managing Data Risk across Regulatory, Privacy, Governance and Cybersecurity vectors. He started his career with IBM in 2012 and would go on to join Deloitte’s Canadian practice in 2015 and EY’s Canadian practice in 2018. In 2021 he would become the CPO at the Edtechn Unicorn – Applyboard where established and led the company’s first Privacy & Data Governance department, program and strategy. His strategic leadership was critical to Applyboard’s success in preventing major operational cost from rapidly evolving regulatory changes across its over 120 countries in which it operated in. He is now currently at Meta, where he works within the Integrity and Risk Launches organization and has successfully helped launch over 300 related AI and ML related projects. He has also helped drive EU Digital Service Act and Digital Markets Act preparedness across multiple Meta products.   

Shawn has worked with market leaders across the globe to drive better business decisions based on enabling and scaling AI technologies through effective risk management and data governance techniques. This includes helping global brands navigate complex regulations and pioneering new frameworks that ensure cutting edge technology empowers society responsibly. He is also a subject matter expert on over 100 different regulations, framework and practices related to data risk. On his spare time, he provides mentorship to start up tech firms in Toronto and is passionate about helping start-ups succeed.

Kate Wilson

Kate Wilson is the Head of Health Equity in Global Clinical Operations at Biogen. Kate has over 20 years of experience in clinical research with an undergraduate degree in Chemistry.

She’s held multiple roles within Global Clinical Operations at and worked across many therapeutic areas including multiple sclerosis and Alzheimer’s disease.

Currently at Biogen, Kate is leading the Health Equity and DE&I in Clinical Trials capabilities to increase the awareness, access and participation of diverse and representative participants in their clinical trials.